Germany
Japan
United Kingdom
China
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Antibodies
View as table Download
Recombinant Anti-Insulin receptor alpha (Clone 83-7)
| Applications | ELISA, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-4 (Clone 11B11)
| Applications | ELISA, FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VAP-1 (Clone 2D10)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IFN gamma (Clone D9D10)
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-2 (Clone LNKB-2)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
| Applications | EIA, ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IgM (Clone M15/8)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Rhodopsin (Clone Rho 1D4)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Zebrafish, Cow |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-C3a-receptor (Clone 3G7)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD98 (Clone CP1-5)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Membrane type 1 metalloprotease (Clone LEM-2/15)
| Applications | Bl, ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-A2A-Adenosine Receptor (Clone Ig2838)
| Applications | Bl, ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Paxillin (LD4 Motif) (Clone LD4 sAB)
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Paxillin (LD2 Motif) (Clone LD2 sAB)
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD11c (Clone N418)
| Applications | ELISA |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-SIRP- beta & gamma (Clone OX117)
| Applications | ELISA, FC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Discoidin Domain Receptor 1 (Clone 3E3)
| Applications | Bl, ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TrkA (Clone MNAC13)
| Applications | Bl, ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone S3 12D)
| Applications | ELISA, ICC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-dsRNA (Clone 1D3)
| Applications | ELISA, IHC, WB |
| Reactivities | Virus |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD28 (Clone 1C6)
| Applications | Bl, ELISA, FC |
| Reactivities | Dog |
| Conjugation | Unconjugated |
Recombinant Anti-Integrin α-M (Clone 107)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD30 (Clone Ki-4)
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-LeY (Clone BR96)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-LeY (Clone H18A)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Prion (Clone 3F4)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Hamster, Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IgE (Clone TES-C21)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Vα TCR (Clone 34)
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Galanin (Clone 4B3)
| Applications | ELISA, ICC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Basigin (Clone Ab-1)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone Matuzumab)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VEGF (Clone VG76e)
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Primate |
| Conjugation | Unconjugated |
Recombinant Anti-GITRL (Clone YGL386)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Isotypes
- IgG1, kappa
Assay Types
- Indirect
Filter by
Category
Target Symbol
- EGFR (4)
- TNF (3)
- VEGFA (3)
- AKT1 (2)
- CCR5 (2)
- CD28 (2)
- CD4 (2)
- CD52 (2)
- ERBB2 (2)
- FN1 (2)
- IL2RA (2)
- LEY (2)
- MSLN (2)
- MUC1 (2)
- N (2)
- NOTCH2 (2)
- PXN (2)
- SLC3A2 (2)
- TIMD4 (2)
- ACKR1 (1)
- ADORA2A (1)
- ADRB2 (1)
- AGER (1)
- AOC3 (1)
- APP (1)
- BETVI (1)
- BSG (1)
- C3AR1 (1)
- CD1A (1)
- CD40LG (1)
- CD74 (1)
- CD81 (1)
- COX1 (1)
- CR1 (1)
- DDR1 (1)
- DSRNA (1)
- EDAR (1)
- EPHA2 (1)
- F (1)
- FAS (1)
- FCAR (1)
- FGB (1)
- G1 (1)
- GAL (1)
- GYPA (1)
- IFNG (1)
- IGE (1)
- IGM (1)
- IL10 (1)
- IL17A (1)
- IL18 (1)
- IL2 (1)
- IL4 (1)
- IL6R (1)
- IL9 (1)
- INSR (1)
- ITGA4 (1)
- ITGA5 (1)
- ITGAM (1)
- ITGAX (1)
- MMP14 (1)
- NCAM1 (1)
- NTRK1 (1)
- PDCD4 (1)
- PRION (1)
- PROC (1)
- RAP (1)
- RHO (1)
- S (1)
- SEPTIN5 (1)
- SIRPG (1)
- SNAP25 (1)
- STAT5A (1)
- TF (1)
- TNFRSF10B (1)
- TNFRSF8 (1)
- TNFRSF9 (1)
- TNFSF18 (1)
- TRAC (1)
- TSPAN1 (1)
- TYRP1 (1)
- VSIR (1)
Reactivities
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (5)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)